• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

撤稿声明:丹参酮IIA通过下调TRPM7和促炎因子减轻脂多糖诱导的急性肺损伤。

Retraction: Tanshinone IIA alleviates lipopolysaccharide-induced acute lung injury by downregulating TRPM7 and pro-inflammatory factors.

出版信息

J Cell Mol Med. 2024 Apr;28(8):e18313. doi: 10.1111/jcmm.18313.

DOI:10.1111/jcmm.18313
PMID:38652091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11037401/
Abstract

Jie Li, Yan Zheng, Ming-Xian Li, Chu-Wei Yang, Yu-Fei Liu, Tanshinone IIA alleviates lipopolysaccharide-induced acute lung injury by downregulating TRPM7 and pro-inflammatory factors. Journal of Cellular and Molecular Medicine, 22: 646-654. https://doi.org/10.1111/jcmm.13350 The above article, published online on 18 October 2017 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by the journal Editor-in-Chief, Stefan Constantinescu, The Foundation for Cellular and Molecular Medicine, and John Wiley and Sons Ltd. The retraction has been agreed upon following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image panels within the article (Figures 1 and 3A) as well as between this (Figure 1) and two other articles that were published previously in different scientific context. Thus, the editors consider the conclusions of this manuscript substantially compromised. The authors were informed about the concerns and the decision to retract but remained unresponsive.

摘要

李洁、郑燕、李明贤、杨楚薇、刘宇飞,丹参酮IIA通过下调TRPM7和促炎因子减轻脂多糖诱导的急性肺损伤。《细胞与分子医学杂志》,22: 646 - 654。https://doi.org/10.1111/jcmm.13350 上述文章于2017年10月18日在线发表于威利在线图书馆(wileyonlinelibrary.com),已被该期刊主编斯特凡·康斯坦丁内斯库、细胞与分子医学基金会以及约翰·威利父子有限公司撤回。在对第三方提出的担忧进行调查后达成了撤回决定,调查发现文章内(图1和3A)以及本文(图1)与之前在不同科学背景下发表的另外两篇文章之间存在不适当的图像重复。因此,编辑们认为该稿件的结论受到了严重影响。已将相关担忧和撤回决定告知作者,但作者未作回应。

相似文献

1
Retraction: Tanshinone IIA alleviates lipopolysaccharide-induced acute lung injury by downregulating TRPM7 and pro-inflammatory factors.撤稿声明:丹参酮IIA通过下调TRPM7和促炎因子减轻脂多糖诱导的急性肺损伤。
J Cell Mol Med. 2024 Apr;28(8):e18313. doi: 10.1111/jcmm.18313.
2
Retraction: The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.撤稿声明:长链非编码RNA-ROR通过靶向miR-206促进骨肉瘤进展。
J Cell Mol Med. 2024 Mar;28(6):e18199. doi: 10.1111/jcmm.18199.
3
RETRACTION: Microrna-379 Suppresses Osteosarcoma Progression by Targeting PDK1.撤稿声明:微小RNA-379通过靶向丙酮酸脱氢酶激酶1抑制骨肉瘤进展。
J Cell Mol Med. 2024 Aug;28(15):e18567. doi: 10.1111/jcmm.18567.
4
Retraction: Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9.撤稿声明:巨噬细胞中Six1表达增加通过调节MMP-9促进肝细胞癌的生长和侵袭。
J Cell Mol Med. 2024 Apr;28(7):e18249. doi: 10.1111/jcmm.18249.
5
RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3.撤回声明:CRNDE的抑制通过调节Mir-545-5p和TIM-3增强CD8 + T细胞对口腔鳞状细胞癌的抗肿瘤活性。
J Cell Mol Med. 2024 Aug;28(15):e18566. doi: 10.1111/jcmm.18566.
6
Retraction: Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.撤回声明:沉默Prrx1b可抑制三阴性乳腺癌细胞的增殖、迁移、侵袭及上皮-间质转化。
J Cell Mol Med. 2024 Apr;28(8):e18312. doi: 10.1111/jcmm.18312.
7
Retraction: Disruption of microRNA-214 during general anaesthesia prevents brain injury and maintains mitochondrial fusion by promoting Mfn2 interaction with Pkm2.撤稿声明:全身麻醉期间微小RNA-214的破坏通过促进Mfn2与Pkm2的相互作用来预防脑损伤并维持线粒体融合。
J Cell Mol Med. 2024 Jan;28(2):e18095. doi: 10.1111/jcmm.18095. Epub 2023 Dec 28.
8
Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging.撤稿声明:LBX2-AS1通过充当Mir-455-5p和Mir-491-5p的海绵来促进E2F2基因表达,从而推动卵巢癌进展。
J Cell Mol Med. 2024 Aug;28(15):e18563. doi: 10.1111/jcmm.18563.
9
Retraction: CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells.撤稿声明:CDK4/6抑制可抑制胶质瘤细胞的肿瘤生长并增强替莫唑胺的疗效。
J Cell Mol Med. 2024 Mar;28(6):e18078. doi: 10.1111/jcmm.18078. Epub 2023 Dec 10.
10
Retraction: miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.撤回声明:在三阴性乳腺癌中,miR-655通过靶向Prrx1抑制上皮-间质转化。
J Cell Mol Med. 2024 Apr;28(8):e18314. doi: 10.1111/jcmm.18314.